JP2023533452A5 - - Google Patents

Info

Publication number
JP2023533452A5
JP2023533452A5 JP2022579739A JP2022579739A JP2023533452A5 JP 2023533452 A5 JP2023533452 A5 JP 2023533452A5 JP 2022579739 A JP2022579739 A JP 2022579739A JP 2022579739 A JP2022579739 A JP 2022579739A JP 2023533452 A5 JP2023533452 A5 JP 2023533452A5
Authority
JP
Japan
Prior art keywords
aneurysm
electron
fatty acid
group
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022579739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533452A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028175 external-priority patent/WO2021262298A1/en
Publication of JP2023533452A publication Critical patent/JP2023533452A/ja
Publication of JP2023533452A5 publication Critical patent/JP2023533452A5/ja
Pending legal-status Critical Current

Links

JP2022579739A 2020-06-23 2021-04-20 動脈瘤を処置するための求電子化合物および求電子プロドラッグ Pending JP2023533452A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063042707P 2020-06-23 2020-06-23
US63/042,707 2020-06-23
PCT/US2021/028175 WO2021262298A1 (en) 2020-06-23 2021-04-20 Electrophilic compounds and electrophilic prodrugs for treating aneurysm

Publications (2)

Publication Number Publication Date
JP2023533452A JP2023533452A (ja) 2023-08-03
JP2023533452A5 true JP2023533452A5 (cg-RX-API-DMAC7.html) 2024-05-01

Family

ID=79281621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022579739A Pending JP2023533452A (ja) 2020-06-23 2021-04-20 動脈瘤を処置するための求電子化合物および求電子プロドラッグ

Country Status (5)

Country Link
US (1) US20230241019A1 (cg-RX-API-DMAC7.html)
EP (1) EP4167977A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023533452A (cg-RX-API-DMAC7.html)
CA (1) CA3186710A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021262298A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4121116A4 (en) * 2020-03-19 2024-06-12 University of Pittsburgh - of the Commonwealth System of Higher Education STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007522118A (ja) 2004-01-30 2007-08-09 ペプリン バイオリピッズ ピーティーワイ エルティーディー 治療用分子および担体分子
WO2005110396A2 (en) 2004-04-28 2005-11-24 Uab Research Foundation Nitrated lipids and methods of making and using thereof
US20110039935A1 (en) 2007-07-02 2011-02-17 Entress Ab Use of pharmacologically active chemical compounds
DE102011103948A1 (de) * 2011-06-06 2012-12-06 B. Braun Melsungen Ag Biopassivierende Beschichtung von Gefäßprothesen mit Nitrocarbonsäuren enthaltenden Phospholipiden
CN106456586A (zh) * 2014-01-24 2017-02-22 国立大学法人京都大学 包含稀有脂肪酸的代谢改善剂
WO2018067709A1 (en) * 2016-10-05 2018-04-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Novel reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions
WO2020081957A1 (en) * 2018-10-19 2020-04-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Magnetic delivery system and hydrogel fixative for therapeutic cells
EP4121116A4 (en) * 2020-03-19 2024-06-12 University of Pittsburgh - of the Commonwealth System of Higher Education STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES
EP4199895A4 (en) * 2020-08-18 2024-11-20 The Regents of The University of Michigan N-ACYL AMINO ACID PRODUCTS AND THEIR USES

Similar Documents

Publication Publication Date Title
JP2024542188A5 (cg-RX-API-DMAC7.html)
JP2024542260A5 (cg-RX-API-DMAC7.html)
RU2001904C1 (ru) Способ получени хиноновых производных
JP2023549011A5 (cg-RX-API-DMAC7.html)
DE69310204T2 (de) Salpetersäureester mit pharmazeutischer wirkung und verfahren zu deren herstellung
PT75649B (de) Neue carbonsaeurederivate verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
JP2018519302A5 (cg-RX-API-DMAC7.html)
KR960029325A (ko) 2,8-이치환된 퀴나졸리논
EP0606012A1 (en) Compositions containing cholesteryl esters of unsaturated fatty acids
JP2014240429A (ja) ビニル置換脂肪酸
CN108430466A (zh) 使用治疗有效量的活化脂肪酸预防、治疗和逆转疾病
DE19975059I2 (de) (2-Oxo-3-tetrahydrothienylcarbamoyl)-alkylthio-essigsäure, ihre Salze und Ester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
JP4553166B2 (ja) ニコチン酸エステルおよびそれを含む薬剤組成物
GB2053924A (en) Immunosuppressive 3-hemiesters of7-oxygenated cholesterol
JP2019529501A (ja) 可逆的に保護された、チオレート化求電子性脂肪酸としてのプロドラッグ
JP2024526305A5 (cg-RX-API-DMAC7.html)
AU2010309756B2 (en) Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
JP2022507265A5 (cg-RX-API-DMAC7.html)
US3147183A (en) Bis-(steroid-21)-dicarboxylic acid esters
EP4628494A1 (en) Phosphatidylamine compound comprising multiple tertiary amino group structures, and composition and use thereof
JP2017537094A5 (cg-RX-API-DMAC7.html)
KR900006124B1 (ko) Gem-디할로 및 테트라할로-1,12-디아미노-4,9-디아자-도데칸 및 이들의 제조방법
JP2001122909A (ja) 重合防止用組成物及びこれを用いる重合防止方法
US3417129A (en) Process for the manufacture of acetoacetic acid methyl ester and acetoacetic acid ethyl ester
NL7908617A (nl) Gesubstitueerde oxycyclohexylazijnzure derivaten, werkwijze voor de bereiding hiervan en geneesmiddel met dit derivaat als actieve component.